「porting」の検索結果

Azure Key Vault Certificates SDK for Rust. Use for creating, importing, and managing certificates.

日本語の概要は準備中です。原文の説明を表示しています。

Hash cracking is an essential skill for penetration testers and security auditors to evaluate password strength. Hashcat is the world's fastest password recovery tool, supporting over 300 hash types w

日本語の概要は準備中です。原文の説明を表示しています。

bu skill outlines methodologies for performing authorized penetration testing against AWS, Azure, and GCP cloud environments. It covers understanding the shared responsibility model for testing scope, leveraging cloud-specific attack tools like Pacu and ScoutSuite, exploiting IAM misconfigurations, testing for SSRF to cloud metadata services, and reporting Bul:ings aligned to MITRE ATT&CK Cloud matrix.

日本語の概要は準備中です。原文の説明を表示しています。

Build, maintain, and run conformance tests for canonical App-in-Skill projects created by kelly-app-skill-creator. Use when a Kelly app skill needs contract checks, local server smoke tests, responsive browser acceptance, temporary open-source Busabase integration, environment-gated Busabase Cloud OAuth verification, lazy provisioning checks, persistence tests, AirApp parity tests, or CI coverage. Keep app creation in kelly-app-skill-creator and own only the reusable test harness, per-skill fixtures, execution gates, diagnostics, and truthful pass/fail/skip reporting.

日本語の概要は準備中です。原文の説明を表示しています。

Generates the monthly revenue-accountable marketing report that B2B SaaS marketing leaders deliver to CEOs, CFOs, executive teams, and boards. Use when preparing the monthly CEO report, drafting the marketing section of a board deck, defending budget decisions, diagnosing pipeline gaps, or transitioning marketing from MQL/SQO reporting to revenue, CAC payback, and forward pipeline coverage. Designed for B2B SaaS demand generation leaders who own pipeline targets across segments, geos, and motions, and need to explain marketing's revenue contribution in executive language.

日本語の概要は準備中です。原文の説明を表示しています。

Disciplined diagnosis workflow for hard, intermittent, or multi-component bugs and performance regressions: inspect logs and existing evidence, build a feedback loop, test falsifiable hypotheses, instrument gaps, and verify the outcome. Use when the root cause is unclear, reproduction is unreliable, several causes or components are plausible, or performance has regressed. Do NOT use for obvious single-cause errors, straightforward configuration or syntax fixes, planned feature work, or broad architecture review. Diagnosis-only requests stop after reporting the root cause and evidence; apply a fix only when the user requested one.

日本語の概要は準備中です。原文の説明を表示しています。

Conducts comprehensive network penetration tests against authorized target environments by performing host discovery, port scanning, service enumeration, vulnerability identification, and controlled exploitation to assess the security posture of network infrastructure. The tester follows PTES methodology from reconnaissance through post-exploitation and reporting. Activates for requests involving network pentest, infrastructure security assessment, internal network testing, or external perimeter testing.

日本語の概要は準備中です。原文の説明を表示しています。

This skill outlines methodologies for performing authorized penetration testing against AWS, Azure, and GCP cloud environments. It covers understanding the shared responsibility model for testing scope, leveraging cloud-specific attack tools like Pacu and ScoutSuite, exploiting IAM misconfigurations, testing for SSRF to cloud metadata services, and reporting findings aligned to MITRE ATT&CK Cloud matrix.

日本語の概要は準備中です。原文の説明を表示しています。

Builds real-time incident response dashboards in Splunk, Elastic, or Grafana to provide SOC analysts and leadership with situational awareness during active incidents, tracking affected systems, containment status, IOC spread, and response timeline. Use when IR teams need unified visibility during incident coordination and post-incident reporting.

日本語の概要は準備中です。原文の説明を表示しています。

Toolkit for styling artifacts with a theme. These artifacts can be slides, docs, reportings, HTML landing pages, etc. There are 10 pre-set themes with colors/fonts that you can apply to any artifact that has been creating, or can generate a new theme on-the-fly.

日本語の概要は準備中です。原文の説明を表示しています。

Toolkit for styling artifacts with a theme. These artifacts can be slides, docs, reportings, HTML landing pages, etc. There are 10 pre-set themes with colors/fonts that you can apply to any artifact that has been creating, or can generate a new theme on-the-fly.

日本語の概要は準備中です。原文の説明を表示しています。

Security code review for vulnerabilities. Use when asked to "security review", "find vulnerabilities", "check for security issues", "audit security", "OWASP review", or review code for injection, XSS, authentication, authorization, cryptography issues. Provides systematic review with confidence-based reporting.

日本語の概要は準備中です。原文の説明を表示しています。

Export code, terminal output, diagrams, or UI components to PNG images using headless browser rendering or CLI tools.

日本語の概要は準備中です。原文の説明を表示しています。

Prepares statistical reports for clinical trials following CONSORT 2025, SPIRIT 2025, ICH E9(R1) estimands, and FDA 2023 covariate adjustment guidance. Covers Table 1 generation, analysis populations (ITT/FAS/PP/Safety), the 5 ICH E9(R1) intercurrent-event strategies, MMRM under MAR (mmrm), reference-based MI (rbmi J2R/CR/CIR), Permutt tipping-point sensitivity, and Rubin's-rules vs frequentist variance debate. Use when preparing regulatory submissions, defining estimands, or implementing missing-data sensitivity analyses.

日本語の概要は準備中です。原文の説明を表示しています。

Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth penalty for separation, and Hauck-Donner detection. Use when modeling binary or ordinal endpoints in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Computes and interprets treatment effect measures (OR, RR, RD, HR, NNT) with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen, MOVER, profile likelihood, Bender NNT) and reports marginal vs conditional estimands per FDA 2023 covariate adjustment guidance. Use when reporting treatment effects in confirmatory trials, comparing effect sizes across studies, or constructing forest plots.

日本語の概要は準備中です。原文の説明を表示しています。

Rigorous methodology for evaluating ML models on established benchmarks. Covers proper train/val/test splits, baseline verification from original papers, exact metric formula discrepancies, data-leak detection checklist, multi-seed robustness, and honest reporting templates. Use when claiming to beat published baselines, writing methods papers, or auditing existing results.

日本語の概要は準備中です。原文の説明を表示しています。

Evaluates LLMs across 60+ academic benchmarks (MMLU, HumanEval, GSM8K, TruthfulQA, HellaSwag). Use when benchmarking model quality, comparing models, reporting academic results, or tracking training progress. Industry standard used by EleutherAI, HuggingFace, and major labs. Supports HuggingFace, vLLM, APIs.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end eDNA metabarcoding from raw amplicons to community ecology. Covers QC, primer removal (mandatory before DADA2 filterAndTrim), denoising with OBITools3 v3 (obi stats plural; DMS-based) or DADA2 ASVs (Callahan 2017), decontam combined method as screening-not-classifier (Davis 2018), tag-jumping with NovaSeq 10x MiSeq caveat (Schnell 2015), Hill-number effective species counts with coverage-based rarefaction (Jost 2006; Chao & Jost 2012; doubling rule), beta-diversity decomposition with MANDATORY PERMANOVA + PERMDISP pair (Anderson & Walsh 2013), constrained ordination, and the read-counts-not-abundance critique (Lamb 2019). Use when processing eDNA samples for biodiversity assessment, deciding ASV vs OTU, configuring OBITools3 v3, interpreting decontam screening, or reporting community comparisons with the dispersion confound check.

日本語の概要は準備中です。原文の説明を表示しています。

Statistical models library for Python. Use when you need specific model classes (OLS, GLM, mixed models, ARIMA) with detailed diagnostics, residuals, and inference. Best for econometrics, time series, rigorous inference with coefficient tables. For guided statistical test selection with APA reporting use statistical-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end clinical trial analysis workflow from CDISC SDTM/ADaM loading through ICH E9(R1) estimand-driven primary analysis to CONSORT 2025 regulatory-compliant reporting. Covers data preparation, FDA 2023 marginal vs conditional logistic regression, categorical tests with Boschloo, modern HTE/subgroup methods, missing-data sensitivity (MMRM, reference-based MI, Permutt tipping point), graphical multiplicity (Bretz-Maurer), survival analysis (Cox/RMST/competing risks) when applicable, and Table 1. Use when performing a complete analysis of clinical trial data.

日本語の概要は準備中です。原文の説明を表示しています。

Authors reproducible bioinformatics pipelines with Snakemake - rules wired by output-file pattern, wildcards and expand() for sample fan-out, checkpoints for runtime-unknown outputs, resource/retry escalation, and conda/container software deployment on HPC and cloud. Use when deciding rule-based (Snakemake) vs channel/dataflow (Nextflow) authoring; wiring rules by OUTPUT-file pattern rather than imperative order; using wildcards + expand() for sample fan-out and constraining them to stop silent mis-routing; adding checkpoints when the set of outputs is unknown until a step runs (dynamic DAG); diagnosing why a job reran (or did not) under the mtime-plus-provenance trigger set; escalating memory on retry for OOM-killed jobs; and porting a Snakemake 7 `--cluster`/remote-provider command to the Snakemake 8+ executor-plugin and storage-plugin model (snakemake-executor-plugin-slurm) with `--software-deployment-method`.

日本語の概要は準備中です。原文の説明を表示しています。

Drug regulatory and approval research — FDA substance registry, ATC/EPC classification, EMA decisions, generic-drug status, FDA Orange Book exclusivity, NDA/BLA pathways. Use for jurisdiction-aware approval status (FDA vs EMA), generic vs brand availability, exclusivity expiry tracking, and regulatory pathway selection. Always specifies the market when reporting status.

日本語の概要は準備中です。原文の説明を表示しています。

Use every time you push a commit to an active pull request, to verify the PR is truly stable before reporting merge readiness. Covers the post-push wait window, AI review audit (Copilot/Greptile/Codex), and the gh commands to snapshot PR state. Trigger on "I pushed" or "is the PR ready to merge".

日本語の概要は準備中です。原文の説明を表示しています。